Dermatitis

Papers
(The TQCC of Dermatitis is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Fragrance Skin Sensitization Evaluation and Human Testing: 30-Year Experience521
North American Contact Dermatitis Group Patch Test Results: 2017–201876
American Contact Dermatitis Society Core Allergen Series: 2020 Update40
The Eczema Area and Severity Index—A Practical Guide40
Hand Hygiene Among Health Care Workers During COVID-19 Pandemic: Challenges and Recommendations34
North American Contact Dermatitis Group Patch Test Results: 2019–202033
Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata27
Financial Burden of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States26
Systemic Therapy for Atopic Dermatitis in Older Adults and Adults With Comorbidities: A Scoping Review and International Eczema Council Survey23
Impact of Gloves and Mask Use on Epidermal Barrier Function in Health Care Workers22
Psoriasis-like Eruption triggered by Dupilumab Therapy18
Patch Testing During Immunosuppressive Therapy: A Systematic Review18
Allergic Contact Dermatitis to Components of Wearable Adhesive Health Devices18
Allergenic Ingredients in Health Care Hand Sanitizers in the United States17
Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab17
Epidemiology and Burden of Sleep Disturbances in Atopic Dermatitis in US Adults15
Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib14
Patch Testing Results From the Massachusetts General Hospital Contact Dermatitis Clinic, 2007–201614
Fragrance- and Botanical-Related Allergy and Associated Concomitant Reactions: A Retrospective Analysis of the North American Contact Dermatitis Group Data 2007–201614
The Interplay of Atopic Dermatitis and Sexual Health13
Mycosis Fungoides Unmasked by Dupilumab Treatment in a Patient With a History of Atopic Dermatitis13
Contact Dermatitis Associated With Hair Care Products: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001–201613
The History of Surfactants and Review of Their Allergic and Irritant Properties13
Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Cutaneous Adverse Reactions: A Review12
Cessation of Long-term Topical Steroids in Adult Atopic Dermatitis: A Prospective Cohort Study11
Cutaneous Reactions to Aluminum11
The Association of Bullous Pemphigoid With Atopic Dermatitis and Allergic Rhinitis—A Population-Based Study10
Nasal Colonization by Staphylococci and Severity of Atopic Dermatitis10
Allergen Content of Best-Selling Ethnic Versus Nonethnic Shampoos, Conditioners, and Styling Products10
Psoralen-Induced Phytophotodermatitis10
Facial Personal Protective Equipment: Materials, Resterilization Methods, and Management of Occupation-Related Dermatoses10
Upadacitinib for the Treatment of Atopic Dermatitis in a Spanish Cohort—Real Life: Fifty-Two–Week Follow-up Results10
Allergic Contact Dermatitis From Topical Drugs: An Overview10
Allergic Contact Dermatitis, an Important Skin Reaction in Diabetes Device Users: A Systematic Review10
Measurement Properties of Patient Health Questionnaire 9 and Patient Health Questionnaire 2 in Adult Patients With Atopic Dermatitis9
Chronic Hand Eczema Guidelines From an Expert Panel of the International Eczema Council9
TikTok as a Source of Dermatologic Information on Atopic Dermatitis9
Atopic Dermatitis in Latin America: A Roadmap to Address Data Collection, Knowledge Gaps, and Challenges9
Rapid Improvement of Itch Associated With Atopic Dermatitis With Abrocitinib Is Partially Independent of Overall Disease Improvement: Results From Pooled Phase 2b and 3 Monotherapy Studies9
Nickel: Intrinsic Skin Sensitization Potency and Relation to Prevalence of Contact Allergy9
Allergic Contact Dermatitis to (Meth)Acrylates in Apple AirPods Headphones9
Acetophenone Azine8
Dupilumab Significantly Modulates Pain and Discomfort in Patients With Atopic Dermatitis: A Post Hoc Analysis of 5 Randomized Clinical Trials8
Positive Patch Test Reactions to Carba Mix and Thiuram Mix: The North American Contact Dermatitis Group Experience (1994–2016)8
Prevalence of Contact Allergens in Best-Selling Ophthalmic Products8
Sunscreens: A Review of UV Filters and Their Allergic Potential7
Mental Health Symptoms and Functional Impairment in Children With Atopic Dermatitis7
Dupilumab in Elderly Patients With Severe Atopic Dermatitis7
Atopic Dermatitis Is Associated With Multiple Behavioral Problems in US Children and Adolescents7
Characterization of Residual Facial Dermatitis during Dupilumab Therapy: A Retrospective Chart Review to Delineate the Potential Role of Expanded Series Patch Testing7
Weight of Evidence Approach for Skin Sensitization Potency Categorization of Fragrance Ingredients7
Aluminum—Allergen of the Year 20227
Photopatch Testing in New Zealand: A 12-Year Retrospective Review7
Occupational Contact Dermatitis in Hospital Cleaning Workers7
Psoriatic Plaques After Initiation of Dupilumab Therapy7
Dystrophic Epidermolysis Bullosa Pruriginosa: Successfully Treated With Dupilumab6
Skin Characteristics of Hairdresser Apprentices at the Beginning of Vocational Training6
Failure of Dupilimab With Severe Prurigo Nodularis That Responded Well to Abrocitinib6
Update on Contact Sensitization in the Older Adult Population6
Contact Dermatitis From Gum Mastic (Pistacia lentiscus) and Gum Storax (Liquidambar styraciflua) in Mastisol-Allergic Patients6
Acute Pancreatitis in 2 Adolescent Boys on Dupilumab Therapy for Atopic Dermatitis6
Salivary Cortisol Values and Personality Features of Atopic Dermatitis Patients: A Prospective Study6
Usefulness of Patch Testing With Patient's Own Products in the Diagnosis of Allergic Contact Dermatitis6
Impact and Associations of Atopic Dermatitis Out-of-Pocket Health Care Expenses in the United States6
Patch Testing in Drug Eruptions: Practical Aspects and Literature Review of Eruptions and Culprit Drugs6
Anti-inflammatory Effect of Cannabidiol and Palmitoylethanolamide Containing Topical Formulation on Skin in a 12-O-Tetradecanoylphorbol-13-Acetate–Induced Dermatitis Model in Mice6
Long-Term Narrowband UV-B Efficacy in Moderate to Severe Atopic Dermatitis6
Occupational Contact Dermatitis in Dental Personnel: A Retrospective Analysis of the North American Contact Dermatitis Group Data, 2001 to 20186
Ocular Adverse Events in Patients With Atopic Dermatitis Treated With Upadacitinib: A Real-Life Experience6
Can We Separate Oral Lichen Planus from Allergic Contact Dermatitis and Should We Patch Test? A Systematic Review of Chronic Oral Lichenoid Lesions6
Off-label Studies on the Use of Ruxolitinib in Dermatology6
Methylchloroisothiazolinone and/or Methylisothiazolinone Contact Allergies in Thailand6
Contact Allergy to Cannabis and Related Essential Oils6
Expanding Patch Testing Beyond the Baseline Series: Usefulness of Customized Antimicrobials, Vehicles, and Cosmetics Series5
Self-Reported Hand Eczema: Assessment of Prevalence and Risk Factors in Health Care Versus Non–Health Care Workers During the COVID-19 Pandemic5
Are Topical Corticoids Efficacious in Acute Irritant Dermatitis: The Evidence5
T Helper 2 Inhibitors in Allergic Contact Dermatitis5
The Effects of Common Over-the-Counter Moisturizers on Skin Barrier Function: A Randomized, Observer-Blind, Within-Patient, Controlled Study5
Further Evidence of Allergic Contact Dermatitis Caused by 2,2′-Methylenebis(6-tert-Butyl-4-Methylphenol) Monoacrylate, a New Sensitizer in the Dexcom G6 Glucose Sensor5
Results of Switching From Tofacitinib to Upadacitinib in Patients With Atopic Dermatitis: A Retrospective Medical Record Review5
Neonatal Bacillus Calmette-Guérin Vaccination to Prevent Early-Life Eczema: A Systematic Review and Meta-analysis5
Efficacy of Dupilumab in Children 6 Months to 11 Years Old With Atopic Dermatitis: A Retrospective Real-World Study in China5
Formaldehyde Release From Predispersed Tattoo Inks: Analysis Using the Chromotropic Acid Method5
Patch Test Clinic Start-up: From Basics to Pearls5
Exploring the Relationship Between Dermatology Life Quality Index, Eczema Area and Severity Index, and Sleep Numerical Rating Scale and Pruritus Numerical Rating Scale in Patients with Atopic Dermatit5
High Levels of Psychological Distress, Sleep Disturbance, and Alcohol Use Disorder in Adults With Atopic Dermatitis5
Transitioning From Immunosuppressants to Dupilumab in Pediatric Atopic Dermatitis5
Patch Testing to Carvone: North American Contact Dermatitis Group Experience, 2009 to 20185
Dupilumab-Induced Palmoplantar Psoriasis: Is It True Psoriasis?5
Wearable Woes: Allergens in Diabetic Devices5
General and Skin-Specific Health-Related Quality of Life in Patients With Atopic Dermatitis Before and During the COVID-19 Pandemic5
Persistence of Isothiazolinones in Clothes After Machine Washing5
Identifying Acrylates in Medical Adhesives5
Allergic Contact Dermatitis of the Scalp Associated With Scalp Applied Products: A Systematic Review of Topical Allergens5
YouTube as a Source of Information on Contact Dermatitis4
Contact Allergy Cross-reactions and Thresholds: A Review4
Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Brodalumab4
Longitudinal Course of Sleep Disturbance and Relationship With Itch in Adult Atopic Dermatitis in Clinical Practice4
Acute Generalized Exanthematous Pustulosis Induced by Topical Morphine and Confirmed by Patch Testing4
Impact of Extracorporeal Photopheresis on Blood Parameters of Atopic Dermatitis Patients4
Association of Childhood Atopic Dermatitis With Atopic and Nonatopic Multimorbidity4
Allergic Contact Dermatitis in the Older Adults: A Comparative Cross-Sectional Study4
Reliability and Longitudinal Course of Itch/Scratch Severity in Adults With Atopic Dermatitis4
Meeting the Needs of Patients With Atopic Dermatitis: A Multidisciplinary Approach4
Potential for Allergic Contact Dermatitis in Popular Hair Care Practices and Ingredients4
Treatment of Checkpoint Inhibitor–Induced Vitiligo in a Patient With Metastatic Renal Cell Cancer4
Friction-Induced Skin Disorders—A Review4
Readability, Quality, and Timeliness of Online Health Resources for Atopic Dermatitis4
Allergic Contact Dermatitis Caused by an Acrylic Nails Kit for Domestic Use4
Palmar Eczema From Secondary 2-Hydroxyethyl Methacrylate Exposure—The Artificial Nail Grip Sign4
Autoimmune Progesterone Dermatitis: A Systematic Review4
Systemic Treatment of Cutaneous Adverse Events After Immune Checkpoint Inhibitor Therapy: A Review4
COVID-19 Outcomes in Pediatric Patients With Atopic Dermatitis: A Multicenter Analysis4
Atopic Dermatitis is a Risk Factor for Rheumatoid Arthritis: A Systematic Review and Meta-Analysis4
The Burden of Coronavirus Disease 2019 and Its Complications in Patients With Atopic Dermatitis—A Nested Case-Control Study4
Occupational Contact Dermatitis Caused by Artichokes4
Bilateral Association Between Atopic Dermatitis and Alopecia Areata: A Systematic Review and Meta-Analysis4
Characterization of Tattoo Aftercare Products: Allergenic Ingredients and Marketing Claims4
Hand Dermatitis in the Time of COVID-19: A Review of Occupational Irritant Contact Dermatitis4
Formaldehyde in Electronic Cigarette Liquid (Aerosolized Liquid)4
Ketotifen in Over-the-Counter Products Is a Contact Allergen4
Multiyear Group and Medical Center Patch Test Frequency Data: Confounding Variables3
Measurement Properties of 4 Patient-Reported Outcome Measures to Assess Sleep Disturbance in Adults With Atopic Dermatitis3
First Short-Term Effectiveness and Security Data of Tralokinumab in Severe Atopic Dermatitis in Real Clinical Practice3
Analysis of Hexavalent Chromium in Cement Samples From Countries Within and Outside the EU: A Study From the International Contact Dermatitis Research Group3
Keep an Eye Out for Loteprednol Etabonate: A New Steroid Allergy3
Men's Facial Moisturizers in the Metrosexual Era3
Prevalence, Predictors, and Longitudinal Course of Sexual Dysfunction in Adults With Atopic Dermatitis3
Lanolin Allergic Reactions: North American Contact Dermatitis Group Experience, 2001 to 20183
Patch Testing Interrupted: Virtual Patch Test Readings During the COVID-19 Pandemic3
Trends in Patch Testing With the Mayo Clinic Standard Series, 2017–20213
Burden of Disease and Unmet Needs in Atopic Dermatitis: Results From a Patient Survey3
Contact Dermatitis in Construction Workers in Northeastern Italian Patch Test Database Between 1996 and 20163
Cutaneous Comorbidities Associated With Atopic Dermatitis in Israel: A Retrospective Real-World Data Analysis3
Pediatric Contact Dermatitis: A 10-Year Multicenter Retrospective Study3
Contact Allergens in Prescription Topical Ophthalmic Medications3
Isothiazolinones Common in Children's Toy Slime3
Topical Crisaborole in the Treatment of Atopic Hand Dermatitis: A Retrospective Chart Review3
Real-World Clinical Experience of Dupilumab in the Treatment of Chronic Palmo-Plantar Eczema in Patients with Moderate-Severe Atopic Dermatitis: 52-Week Follow-Up3
Patch Testing With an Extended Metal Allergen Series at the Massachusetts General Hospital (2006–2017)3
Incidence of Bacterial and Nonbacterial Conjunctivitis in Patients With Atopic Dermatitis Treated With Dupilumab: A US Multidatabase Cohort Study3
Work-Related and Personal Predictors of Hand Eczema in Physicians and Dentists: Results From a Field Study3
Patch Test Results to European Baseline Series in Turkey: A Prospective and Multicenter Study3
Assessment and Monitoring Challenges Among Patients With Moderate-to-Severe Atopic Dermatitis Across Fitzpatrick Skin Types: A Photographic Review and Case Series3
Lanolin3
Association of Adult Atopic Dermatitis Severity With Decreased Physical Activity: A Cross-sectional Study3
Patch Testing With Cobalt in Adults: A North American Contact Dermatitis Group Experience, 2001–20183
Long-Term North American Trend in Patch Test Reactions: A 32-Year Statistical Overview (1984–2016)3
Dupilumab-Induced Extrafacial Paradoxical Persistent Erythema in an Atopic Dermatitis Patient3
A Retrospective Review of Late Delayed Positive Patch Testing Greater Than Day 8 at Mayo Clinic From 2001 to 20203
Objective Sleep in Atopic Dermatitis: A Meta-Analysis3
Childhood Atopic Dermatitis Is Not Associated With Maternal Alcohol Use During Pregnancy or Adolescent Alcohol Use3
Dupilumab for Atopic Dermatitis—From Clinical Trials to Molecular and Cellular Mechanisms3
A Survey of Skin Reactions Associated With Acrylic Nail Cosmetics, With a Focus on Home Kits: Is There a Need for Regulation?3
A Different Type of Second Wave: A Predicted Increase in Personal Protective Equipment–Related Allergic Contact Dermatitis as a Result of Coronavirus Disease 20193
Atopic Dermatitis and Difficult-to-Treat Areas: A Case Series of Four Patients With Dupilumab-Resistant Primary Atopic Blepharitis and Successfully Treated With Upadacitinib3
Ethanol-Based Disinfectants Containing Urea May Reduce Soap Sensitivity3
Too Much of a Good Thing? Allergic Contact Dermatitis to Pimecrolimus3
Rate of Patch Testing Induced Anaphylaxis3
Consort Allergic Contact Dermatitis: A Systematic Review3
Patterns of Allergic Contact Dermatitis in African Americans in a Major Metropolitan Area Over a 10-Year Period3
Cutaneous Vasculitis Caused by Clindamycin2
The Prevalence of Type IV Hypersensitivity in Patients With Lichen Planopilaris and Frontal Fibrosing Alopecia2
Dupilumab for Atopic Dermatitis—From Clinical Trials to Molecular and Cellular Mechanisms2
“Mango Slice” Dermatitis: Pediatric Allergic Contact Dermatitis to Mango Pulp and Skin2
Patch Testing to Methyldibromoglutaronitrile/Phenoxyethanol: North American Contact Dermatitis Group Experience, 1994–20182
Patch Testing in Patients With Severe Atopic Dermatitis Treated With Dupilumab: A Multicentric Approach in Spain2
Development of an Eczema Area and Severity Index Atlas for Diverse Skin Types2
Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis Overlap After the Third Dose of BNT162b2 mRNA COVID-19 Vaccination and Literature Review2
Discordance Between Diagnosis Tools for Assessing Eczema in Infants: A Challenge for Intervention Trials2
Readability, Quality, and Comprehensiveness of Patient Online Health Resources for Hand Dermatitis2
Allergic Contact Dermatitis to Pramoxine (Pramocaine)2
Contact Dermatitis in the Surgical Patient: A Focus on Wound Closure Materials2
Our Approach to Textile Dermatitis: In-Clinic Dye Extraction2
The Frequency and Utility of Drug Cessation Trials in Older Adults With Chronic Eczematous Dermatitis of Unknown Etiology: A Retrospective Cohort Study2
Isothiazolinone Detection in Dish Soap and Personal Care Products: Comparison of Lovibond Isothiazolinone Test Kit and Ultrahigh-Performance Liquid Chromatography–Tandem Mass Spectrometry2
Tofacitinib, a JAK1/3 Inhibitor As Treatment for Linear IgA Bullous Dermatosis: A Case Report2
Shoe Allergens: A Retrospective Analysis of Cross-sectional Data From the North American Contact Dermatitis Group, 2005–20182
Patch Testing Results From the Massachusetts General Hospital Occupational and Contact Dermatitis Clinic, 2017–20222
Allergic Contact Dermatitis Associated With Religious Practices: Review of the Literature2
Cetrimonium Bromide Patch Test Positivity Is Found With a High Frequency in a Cohort of Patients With Frontal Fibrosing Alopecia2
Frequency of Allergenic Ingredients in Antifungal Creams2
Sulfites: Allergen of the Year 20242
Patch Testing of Mercaptobenzothiazole and Mercapto Mix: The North American Contact Dermatitis Group Experience, 1994–20162
Norwegian Scabies in an Atopic Patient Under Dupilumab Treatment2
Safety and Efficacy of Dupilumab in an Atopic Adolescent With Primary Immune Deficiency2
A Review of Dupilumab-Induced Adverse Events to Dermatologists and the Potential Pathogenesis in the Treatment of Atopic Dermatitis2
Patients' and Caregivers' Preferences for Mental Health Care and Support in Atopic Dermatitis2
American Contact Dermatitis Society Position Statement: Dermatitis and Skin of Color2
Contact Allergy to Two Aluminum Salts in Consecutively Patch-Tested Dermatitis Patients2
Patch Testing With Tocopherol and Tocopherol Acetate: The North American Contact Dermatitis Group Experience, 2001 to 20162
Effectiveness of Support Groups for Patients With Contact Dermatitis: A Pilot Study2
A Case of Pigmented Contact Dermatitis Caused by Ethylhexylglycerin2
Potential Allergens in Wound Care Products2
Two Cases of Erythema Annulare Centrifigum Triggered by COVID-19 Vaccination2
Effectiveness of a Skin Care Program With a Cream Containing Ceramide C and a Personalized Training for Secondary Prevention of Hand Contact Dermatitis2
Successful Treatment of Atopic Hand and Foot Eczema With Oral Janus Kinase 1 Inhibition2
Establishing Consensus on the Treatment of Toxicodendron Dermatitis2
Association of Childhood Atopic Dermatitis With a Higher Risk of Health Care Utilization and Drug Use for Asthma: A Nationwide Cohort Study2
An Approach to Hypereosinophilic Syndrome Presenting With Cutaneous Features2
Atopic Dermatitis as a Risk Factor for Herpes Zoster Infection Independent of Treatment: A Nationwide Population-Based Cohort Study2
Contact Allergens in Beard Care Products2
Readability, Quality, and Timeliness of Patient Online Health Resources for Contact Dermatitis and Patch Testing2
Trichoscopy Features of Allergic Contact Dermatitis of the Scalp: A Prospective Case Series2
Association of Adult Atopic Dermatitis Severity With Bacterial, Viral, and Fungal Skin Infections2
Allergic Contact Dermatitis and Patch Testing in Skin of Color Patients2
Allergic Contact Dermatitis in Sexual and Gender Minority Patients: Disparities and a Call to Action2
ACDS 33rd Annual Meeting Abstracts, Thursday, March 24, 2022, Boston2
Pooled Analysis of Baricitinib Tolerability in Patients With Atopic Dermatitis in Relation to Acne, Headache, and Gastrointestinal Events From 8 Clinical Trials2
Patch Testing With Carmine 2.5% in Petrolatum by the North American Contact Dermatitis Group, 2011–20122
Remission of Severe Eyelid Dermatitis With a Topical Janus Kinase Inhibitor2
The 2-Methoxymethyl Modification of p-Phenylenediamine Reduces the Sensitization Risk for Hairdressers to Hair Dyes—An Occupational Hand Exposure–Based Risk Assessment2
Validity of the Skindex Mini in Patients With Atopic Dermatitis2
Patch Testing With Benzophenone-3 and -4: The North American Contact Dermatitis Group Experience, 2013–20202
The Diagnostic Value of Delayed-Type Reactions to Perennial Aeroallergens for Atopic Disease2
Patch Testing With Methylchloroisothiazolinone/Methylisothiazolinone Using a New Diagnostic Mix—A Multicenter Study From the International Contact Dermatitis Research Group2
The Association Between Allergic Contact Dermatitis and Erythema Multiforme: A Systematic Review of the Literature2
Friction-Aggravated Skin Disorders—A Review of Mechanism and Related Diseases2
Patch Testing to Diphenylguanidine by the North American Contact Dermatitis Group (2013–2016)2
Atopic Dermatitis Biomarkers and the Movement Toward Personalized Treatment2
Methyldibromoglutaronitrile: Increased Incidence, but Lacks Clinical Relevance2
Which Clinical Measurement Tools for Atopic Dermatitis Severity Make the Most Sense in Clinical Practice?2
Allergic Contact Dermatitis to the Ethylenediamine Component of Aminophylline in a Neck Cream2
Allergic Sensitization to Nickel and Implanted Metal Devices: A Perspective2
Summertime Dermatitis: When the Repellent Is the Culprit, Not the Bugs!2
Patch Test Reactions Associated With Topical Medications: A Retrospective Analysis of the North American Contact Dermatitis Group Data (2001–2018)2
Utility of Allergen-Specific Patient-Directed Handouts Generated by Chat Generative Pretrained Transformer2
Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy2
Improvement of Pruritus and Efficacy in the Early Stage of Therapy with Upadacitinib, Abrocitinib, or Dupilumab in Chinese Patients with Moderate-to-Severe Atopic Dermatitis: Prospective, Cohort, Obse2
Navigating Tattoo-Related Allergic Dermatitis: Beyond Pigments2
0.04060697555542